Skip to main content
3D Printing of Pharmaceuticals
Introduction
• 3D printing is an additive manufacturing
process in which dosage forms are created
layer by layer.
• It allows precise fabrication of personalized
medicines with controlled drug release and
unique geometries.
Definition
• 3D printing in pharmaceuticals refers to the
fabrication of drug delivery systems using
computer-aided design (CAD) and additive
manufacturing technologies.
Principle of 3D Printing
• Step 1: Design dosage form using CAD
software
• Step 2: Convert design into printable file
• Step 3: Layer-by-layer deposition of material
• Step 4: Final solid dosage form is obtained
Need for 3D Printing
• Personalized therapy
• Patient-specific dosing
• Complex dosage forms
• Combination therapy (polypills)
• Rapid prototyping and reduced waste
Historical Background
• 1980s: Development of additive
manufacturing
• 2015: First FDA-approved 3D printed tablet –
Spritam (Levetiracetam)
• Developed by Aprecia Pharmaceuticals
FDA Approved Product
• Spritam (Levetiracetam)
• Used for epilepsy treatment
• Prepared by ZipDose technology
• Highly porous tablet with rapid disintegration
Classification of Techniques
• 1. Inkjet Printing
• 2. Fused Deposition Modeling (FDM)
• 3. Stereolithography (SLA)
• 4. Selective Laser Sintering (SLS)
• 5. Semi-solid Extrusion
Inkjet Printing
• Drug solution is sprayed onto powder bed
• Suitable for low-dose potent drugs
• Provides accurate dosing and fast
disintegration
Fused Deposition Modeling (FDM)
• Drug-loaded polymer filament is heated and
extruded
• Useful for sustained release tablets
• Common polymers: PLA, PVA, HPMC
Stereolithography (SLA)
• Uses UV laser to solidify photopolymer resin
• Provides high precision and smooth surface
finish
• Useful for implants and complex devices
Selective Laser Sintering (SLS)
• Laser fuses powder particles to form dosage
form
• No need for solvent
• Suitable for heat-stable drugs
Semi-solid Extrusion
• Paste or gel-like material is extruded
• Useful for thermolabile drugs
• Suitable for chewable and pediatric
formulations
Materials Used
• Polymers: PVA, PLA, HPMC, Eudragit
• Excipients: Binders, disintegrants, plasticizers
• Drug substances based on stability and
compatibility
Applications
• Personalized medicine
• Polypills
• Modified release systems
• Pediatric and geriatric formulations
• Implantable devices
Personalized Medicine
• Customized dose according to patient need
• Useful in oncology, pediatrics, geriatrics, and
chronic diseases
• Improves therapeutic outcomes
Advantages
• Accurate dosing
• Customized shape and design
• Improved patient compliance
• Reduced manufacturing waste
• On-demand production
Limitations
• High equipment cost
• Regulatory uncertainty
• Limited printable excipients
• Difficulty in large-scale manufacturing
Future Scope
• AI-assisted formulation design
• Hospital-based medicine printing
• Remote manufacturing
• Bioprinting and implantable systems
Conclusion & References
• 3D printing is transforming pharmaceutical
manufacturing by enabling personalized and
advanced dosage forms.
• References:
• 1. Norman J et al., AAPS PharmSciTech, 2017
• 2. Jamróz W et al., Pharm Res, 2018
• 3. Trenfield SJ et al., Adv Drug Deliv Rev, 2019
• 4. FDA, Spritam Approval, 2015